Bristol-Myers Sues Teva To Block Generic Baraclude
By Shannon Henson · September 24, 2010, 12:19 PM EDT
Bristol-Myers Squibb Co. has slapped Teva Pharmaceutical Industries Ltd. with a lawsuit, accusing it of infringing a patent covering the hepatitis B drug Baraclude....
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login